|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:businessModel
|
Active Pharmaceutical Ingredients (APIs)
Finished Dosages
Pharmaceutical Formulation Intermediates (PFIs)
|
|
gptkbp:CEO
|
Krishna Prasad Chigurupati
|
|
gptkbp:certification
|
gptkb:US_FDA
gptkb:TGA_Australia
gptkb:WHO-GMP
gptkb:Health_Canada
EDQM
|
|
gptkbp:country
|
gptkb:India
|
|
gptkbp:exportedTo
|
gptkb:Africa
gptkb:Asia
gptkb:Europe
gptkb:Latin_America
gptkb:United_States
|
|
gptkbp:foundedYear
|
1984
|
|
gptkbp:founder
|
Krishna Prasad Chigurupati
|
|
gptkbp:headquarters
|
gptkb:Hyderabad
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Granules India Hyderabad
|
|
gptkbp:industry
|
Pharmaceuticals
|
|
gptkbp:ISIN
|
INE101D01020
|
|
gptkbp:listedOn
|
gptkb:NSE
BSE
|
|
gptkbp:locatedIn
|
gptkb:Hyderabad
|
|
gptkbp:manufacturingFacilities
|
gptkb:Hyderabad
gptkb:Vizag
Jeedimetla
Gagillapur
|
|
gptkbp:marketCap
|
over $1 billion (as of 2023)
|
|
gptkbp:numberOfEmployees
|
~3000
|
|
gptkbp:products
|
gptkb:Metformin
gptkb:Ibuprofen
gptkb:Paracetamol
|
|
gptkbp:stockExchange
|
gptkb:NSE
BSE
|
|
gptkbp:type
|
gptkb:public_company
|
|
gptkbp:website
|
https://www.granulesindia.com/
|
|
gptkbp:bfsParent
|
gptkb:Madhapur,_Hyderabad
|
|
gptkbp:bfsLayer
|
7
|